PASADENA, Calif., November 18, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA ...

Parched uplands and forests – save some parts of the Arrowhead region – are the norm, as are receding wetlands, shallow lakes, and river systems. At 5 a.m. sharp on Thursday, Nov. 7, two days before ...